Page last updated: 2024-10-31

moxisylyte and Hypothyroidism

moxisylyte has been researched along with Hypothyroidism in 1 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valcavi, R1
Dieguez, C1
Azzarito, C1
Artioli, C1
Portioli, I1
Scanlon, MF1

Other Studies

1 other study available for moxisylyte and Hypothyroidism

ArticleYear
Alpha-adrenoreceptor blockade with thymoxamine reduces basal thyrotrophin levels but does not influence circadian thyrotrophin changes in man.
    The Journal of endocrinology, 1987, Volume: 115, Issue:1

    Topics: Adult; Circadian Rhythm; Female; Humans; Hypothyroidism; Middle Aged; Moxisylyte; Prolactin; Thyrotr

1987